{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:46Z","timestamp":1791357106036,"version":"4.3.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.pnpbp.2005.11.030","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T19:06:46Z","timestamp":1137697606000},"page":"724-727","source":"Crossref","is-referenced-by-count":15,"title":["Obsessive compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: A case report"],"prefix":"10.1016","volume":"30","author":[{"given":"Suzan","family":"\u00d6zer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Arsava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayg\u00fcn","family":"Ertu\u011frul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ba\u015faran","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2005.11.030_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/jnp.9.1.1","article-title":"The role of serotonin in the pathophysiology and treatment of schizophrenia","volume":"9","author":"Abi-Dargham","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib2","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0920-9964(98)00032-2","article-title":"Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response","volume":"32","author":"Arranz","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4088\/JCP.v61n0910","article-title":"Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases","volume":"61","author":"Aubry","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib5","first-page":"795","article-title":"The serotonin hypothesis of obsessive-compulsive disorder","volume":"5","author":"Barr","year":"1993","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4088\/JCP.v66n0110","article-title":"Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study","volume":"66","author":"Bogan","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4088\/JCP.v63n0807","article-title":"Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study","volume":"63","author":"Denys","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0140-6736(05)78746-8","article-title":"5-HT2A promoter polymorphism \u2014 1438G\/A, anorexia nervosa, and obsessive-compulsive disorder","volume":"351","author":"Enoch","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0924-977X(00)00133-4","article-title":"D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study","volume":"11","author":"Gefvert","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib11","first-page":"55","article-title":"Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS","volume":"26","author":"Khullar","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.jcp.0000150226.84371.76","article-title":"Dopamine D3 receptor Ser9Gly polymorphism and risperidone response","volume":"25","author":"Lane","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0278-5846(03)00039-3","article-title":"Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases","volume":"27","author":"Lykouras","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","article-title":"A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder","volume":"57","author":"McDougle","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib15","series-title":"Presentation at the 155th annual meeting of the American Psychiatric Association, Philadelphia, PA, May, 18\u201323","article-title":"Quetiapine produces preferential occupancy of extrastriatal D2 receptors","author":"Meltzer","year":"2002"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00023210-199809030-00005","article-title":"Potential of atypical antipsychotics in the treatment of non-psychotic disorders","volume":"9","author":"Potenza","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2004.03.011","article-title":"Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review","volume":"82","author":"Sareen","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.b.20045","article-title":"Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia","volume":"124","author":"Szekeres","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2005.11.030_bib20","first-page":"15","article-title":"Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap","volume":"24","author":"Tibbo","year":"1999","journal-title":"J Psychiatry Neurosci"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858460500401X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858460500401X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T03:51:29Z","timestamp":1547869889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858460500401X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S027858460500401X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2005.11.030","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}